CJC-1295 + Ipamorelin Blend

CJC-1295 + Ipamorelin Blend is a 10 mg lyophilized research vial that combines two synthetic growth hormone secretagogue peptides: CJC-1295 without DAC, a 29-residue modified fragment of growth hormone-releasing hormone (GHRH), and Ipamorelin, a five-residue ghrelin-receptor agonist. The batch certificate for this listing identifies the CJC-1295 component specifically as the no-DAC form and reports each peptide separately at 5 mg. Its batch certificate is posted on this page. Supplied strictly for laboratory research.

Research reagent identity

Research literature

This vial combines two synthetic peptides used in endocrine receptor research: CJC-1295 without DAC, a 29-residue analog of GHRH(1-29), and ipamorelin, a pentapeptide ligand of the growth hormone secretagogue receptor (GHS-R1a). Each component has its own primary literature. Primary sources are linked below for researchers who need the original papers. This listing does not summarise study outcomes and makes no claim about any effect, use or benefit of this product, which is supplied as a reference material for in vitro laboratory research only.

References (PubMed): PMID 15817669, PMID 16352683, PMID 17018654, PMID 9849822, PMID 10496658, PMID 8688086, PMID 10604470, PMID 2108187, PMID 19240251

Batch documentation

The certificate card on this page shows lot RRL-5583809-P, Horizon Analytical (horizonanalytical.com), dated 27 JUN 2026. The linked purity PDF lists Revitalized Research LLC as client, a lab-received date of 06/23/2026 and analysis on 06/27/2026 by ultra-high-performance liquid chromatography with mass spectrometry (UPLC-MS). It reports the two components on separate pages: CJC-1295 no DAC, 4.96 mg found against a 5 mg specification, purity 99.13%; Ipamorelin, 4.96 mg found against 5 mg, purity 99.3%. The 99.3% shown on the card is the Ipamorelin figure. A separate endotoxin report, lot RRL-5583809-E, gives <0.05 EU/mL for the blend.

To match a vial to its paperwork, compare the lot number on the vial label with the lot on the card and inside the PDF; the -P and -E suffixes mark the purity and endotoxin reports for the same batch. The PDF notes the report is searchable via horizonanalytical.com. All posted certificates are collected in the COA library, and our guide on how to verify a peptide COA walks through confirming a report with the issuing lab. Batch certificates are posted when available.

Storage and handling

As a dry lyophilized powder the blend is best kept sealed, cold and protected from light and moisture until use. Reconstitution water is not included; reconstitution solution is listed separately for labs that use it. Handle the material only in a laboratory setting with gloves and eye protection,. Peptide storage basics for research labs covers temperature, light and freeze-thaw practice. Related listings: the single Ipamorelin vial or the CJC-1295 + Ipamorelin pen.

Frequently asked questions

Is the CJC-1295 in this blend the DAC or the no-DAC version?

The batch certificate names the component “CJC-1295 no DAC”: the 29-residue tetrasubstituted GHRH(1-29) amide (often called Mod GRF 1-29), molecular formula C152H252N44O42, about 3367.9 g/mol. It does not carry the maleimidopropionyl-lysine (DAC) group, so it is a different compound from CJC-1295 with DAC.

What does the certificate for this blend report?

Lot RRL-5583809-P from Horizon Analytical (analysis conducted 06/27/2026, UPLC-MS) reports each component separately: CJC-1295 no DAC at 4.96 mg against a 5 mg specification with 99.13% purity, and Ipamorelin at 4.96 mg against 5 mg with 99.3% purity. The companion endotoxin report RRL-5583809-E lists a result of <0.05 EU/mL.

How does the vial blend differ from the CJC-1295 + Ipamorelin pen listing?

This listing is a single lyophilized 10 mg vial holding both peptides as dry powder. The pen listing is a separate pre-filled format with its own handling notes and its own batch paperwork; check the certificate on the listing you order.

How should the lyophilized blend be stored in the lab?

Keep the sealed vial cold, dry and away from light, and record the lot number on receipt. Reconstitution solvent is sold separately; stability in solution follows your laboratory’s own protocol.

For research use only. Not for human or animal consumption, administration, injection, topical use, medical, clinical, veterinary, food, cosmetic, supplement, household, or other personal use. This site does not provide medical advice, and this product is not intended to diagnose, treat, cure, mitigate, or prevent any disease.

These statements have not been evaluated by the Food and Drug Administration. Review the available COA or batch documentation and follow applicable laws, institutional protocols, and safety procedures before handling.

Batch documentation for CJC-1295 + Ipamorelin Blend is organized by product, selected variant, and available lot when supplied. Review available COA records, purity or quality documentation, and product identifiers before purchase and before any laboratory handling.

If documentation is not displayed for a selected size or lot, contact support before ordering. Documentation is provided for research recordkeeping and product verification only.

Keep this material sealed until controlled laboratory handling. Store and handle only according to the product label, available COA or SDS, institutional SOPs, and applicable laws.

Use appropriate personal protective equipment and restrict access to qualified personnel. This material is not for human or animal consumption, administration, injection, topical use, medical, clinical, veterinary, food, cosmetic, supplement, household, or other personal use. Dispose of waste according to laboratory protocol and local requirements.